Joben Bio-Medical Co Ltd is a Taiwan-based company mainly engaged in the development and sale of new plant medicines, local Chinese herbal medicines, health foods and medical beauty products. The Company develops JBM-TC4 plant new drug, which has been patented, used to provide raw materials for cancer treatment drugs.

Employees

Sector

Biotechnology & Medical Research

More about the company

End-of-day quote Taipei Exchange 18/10/2019			5-day change	1st Jan Change
10.50 ^TWD	+0.96%		+8.81%	-

13/08/19	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	CI
15/04/19	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	CI

Market Cap	641M 20.34B 572M 533M 485M 913M 61.71B 919M 6.43B 2.5B 31.5B 2.41B 2.35B 101B	P/E 2017	53.5x	P/E 2018	-22.8x
Enterprise Value	867M 27.54B 774M 721M 656M 1.24B 83.54B 1.24B 8.71B 3.39B 42.64B 3.26B 3.19B 137B	EV / Sales 2017	5.87x	EV / Sales 2018	15.8x
Free-Float	82.63%	Yield 2017	0.07%	Yield 2018	-

13/08/19	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	CI
15/04/19	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	CI

Director	Title	Age	Since
Wen Tien Huang CHM	Chairman	-	20/05/2010
Man Hsia Chia BRD	Director/Board Member	-	20/05/2010
Chao Yuan Kuo BRD	Director/Board Member	-	24/06/2011

JBM Stock

Stocks

4193

TW0004193008

Biotechnology & Medical Research

Valuation: JBM

Latest news: JBM

Quotes and Performance

Managers and Directors: JBM

Other Biotechnology & Medical Research

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JBM	+0.96%	+8.81%	-	-	21.03M
WUXI APPTEC CO., LTD.	+4.16%	+3.04%	+49.37%	+94.17%	74.16B
ARGENX SE	-0.37%	-3.88%	+19.75%	+78.35%	57.39B
LONZA GROUP AG	+1.63%	+0.98%	+3.83%	+38.21%	47.64B
REVOLUTION MEDICINES, INC.	+0.50%	+1.32%	+344.62%	+753.25%	44.29B
IQVIA HOLDINGS INC.	+3.05%	-1.58%	+28.78%	+35.46%	42.5B
BEONE MEDICINES AG	+1.00%	+0.22%	+5.17%	+113.80%	40.71B
CELLTRION, INC.	-0.54%	+2.93%	+9.31%	+54.06%	30.97B
WUXI BIOLOGICS (CAYMAN) INC.	+1.56%	+4.53%	+31.34%	+26.92%	28.53B
BIONTECH SE	+0.76%	-0.89%	-7.44%	-11.43%	24.34B
Average	+1.25%	+0.35%	+53.86%	+131.42%	39.06B
Weighted average by Cap.	+1.52%	-0.84%	+58.06%	+140.75%

	2017	2018
Net sales	554M 17.59B 494M 460M 419M 789M 53.36B 795M 5.56B 2.16B 27.23B 2.08B 2.03B 87.53B	192M 6.11B 172M 160M 146M 274M 18.53B 276M 1.93B 752M 9.46B 722M 707M 30.4B
Net income	60.66M 1.93B 54.11M 50.41M 45.88M 86.4M 5.84B 87.04M 609M 237M 2.98B 228M 223M 9.58B	-123M -3.92B -110M -103M -93.28M -176M -11.88B -177M -1.24B -482M -6.06B -463M -453M -19.49B
Net Debt	2.35M 74.58M 2.1M 1.95M 1.78M 3.35M 226M 3.37M 23.59M 9.18M 115M 8.82M 8.63M 371M	227M 7.2B 202M 188M 171M 323M 21.84B 325M 2.28B 886M 11.14B 851M 833M 35.82B